FindTrial
Sign In

The clinical value of serum amyloid A (SAA) in the assessment of asthma exacerbations, lung function, and asthma prognosis in children

The association of serum amyloid A (SAA) and asthma prognosis in children

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200065868
Enrollment
Unknown
Registered
2022-11-17
Start date
2022-11-18
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma

Interventions

Case series:None

Sponsors

Chongqing Medical University Affiliated Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1. Children aged 0 to 18 years with a clinical diagnosis of asthma by pediatricians; 2. With the measurement of SAA level; 3. With a regular follow-up.

Exclusion criteria

Exclusion criteria: 1. Children with cystic fibrosis, bronchopulmonary dysplasia; 2. Unrepaired cardiovascular disease; 3. Structural airway malformation, neuromuscular disorder, immune deficiency, chromosomal abnormalities; 4. Severe systemic disease.

Design outcomes

Primary

MeasureTime frame
the frequence of asthma exacerbation;poor prognosis of asthma;—

Secondary

MeasureTime frame
lung funtion;—

Countries

China

Contacts

Public ContactZhengxiu Luo

Chongqing Medical University Affiliated Children's Hospital

luozhengxiu816@hospital.cqmu.edu.cn+86 13996012755

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026